🇺🇸 FDA

Company profile · Sponsor

Anhui

Anhui Hemay Pharmaceutical Co., Ltd

CE69601 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Anhui (CE69601) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CE69601
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Hemay005 tablet

    Anhui

    Chronic Obstructive Pulmonary Disease

    phase 1 small molecule completed

    1 trial

  2. Purified Protein Derivative of BCG（BCG-PPD）

    Anhui

    Tuberculosis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Anhui?

Anhui (CE69601) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Anhui sponsor?

We track 2 ClinicalTrials.gov-linked programs for Anhui, including Hemay005 tablet and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Anhui company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.